Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

4.90
Delayed Data
As of Dec 11
 -0.15 / -2.97%
Today’s Change
2.35
Today|||52-Week Range
8.25
+100.00%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close5.05
Today’s open5.10
Day’s range4.75 - 5.20
Volume314,017
Average volume (3 months)315,887
Market cap$278.0M
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+81.94%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratioNM
Price/Sales87.21
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...-1.29-10.99%
CPRXCatalyst Pharmaceuti...+0.20+5.00%
DRRXDURECT Corp0.000.00%
STMLStemline Therapeutic...+0.38+2.53%
Data as of 4:00pm ET, 12/11/2017

Financials

Next reporting dateMarch 20, 2018
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts